dsdsa

product

Reasonable price Ganciclovir - Pharmaceutical Grade 1009119-65-6 Daclatasvir For Treatment of Hepatitis C – Yibai

Short Description:


Product Detail

FAQ

Product Tags

Related Video

Feedback (2)

Our business has been focusing on brand strategy. Customers' pleasure is our best advertising. We also offer OEM company for Ganciclovir, Tofacitinib Citrate Api, 25316-40-9, Leading the trend of this field is our persistent goal. Providing first class products is our aim. To create a beautiful future, we would like to cooperate with all friends at home and abroad. Should you have any interest in our products, please do not hesitate to contact us.
Reasonable price Ganciclovir - Pharmaceutical Grade 1009119-65-6 Daclatasvir For Treatment of Hepatitis C – Yibai Detail:

Product name Daclatasvir 2HCl
Synonyms N,N’-[[1,1'-Biphenyl]-4,4′-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid dimethyl ester hydrochloride; BMS 790052
CAS No. 1009119-65-6
Appearance White to pale yellow powder
Molecular Formula C40H50N8O6.2(HCl)
Molecular Weight 811.81
Usage Pharmaceutical Grade for Research purpose
Packing As per your request
Storage Preserve in tight,light-resistant containers in a cool place

 

Daclatasvir 2HCl Cas: 1009119-65-6

Items

Standard

Results

Characteristics White to pale yellow powder Pale-yellow powder
Water content ≦1.0% 0.25%
Purity ≧99% 99.7%
Single impurity ≦0.1% 0.06%
Residue on ignition ≦0.1% Complies
Conclusion Complies with the in-house specification.

Company Information

√ Management layer’s full experience in factory and skilled technicians followers;
√ Quality is always our top consideration, Strict QC system;
√ 11 years experienced exporting sales team;
√ Independent R&D lab;
√ Two signed long term GMP workshops;
√ Rich resources of plenty idle factories for customized project;
√ High Efficiency working team with consistent path.
imgsafSDGSHDASFG

Product detail pictures:

Reasonable price Ganciclovir - Pharmaceutical Grade 1009119-65-6 Daclatasvir For Treatment of Hepatitis C – Yibai detail pictures

Reasonable price Ganciclovir - Pharmaceutical Grade 1009119-65-6 Daclatasvir For Treatment of Hepatitis C – Yibai detail pictures

Reasonable price Ganciclovir - Pharmaceutical Grade 1009119-65-6 Daclatasvir For Treatment of Hepatitis C – Yibai detail pictures


Related Product Guide:

Our goal is to provide high quality products at competitive prices, and top-notch service to customers around the world. We are ISO9001, CE, and GS certified and strictly adhere to their quality specifications for Reasonable price Ganciclovir - Pharmaceutical Grade 1009119-65-6 Daclatasvir For Treatment of Hepatitis C – Yibai , The product will supply to all over the world, such as: Turkey, Zurich, Costa Rica, Based on our guiding principle of quality is the key to development, we continually strive to exceed our customers' expectations. As such, we sincerely invite all interested companies to contact us for future cooperation, We welcome old and new customers to hold hands together for exploring and developing; For more information, be sure to feel free to contact us. Thanks. Advanced equipment, strict quality control, customer-orientation service, initiative summary and improvement of defects and extensive industry experience enable us to guarantee more customer satisfaction and reputation which, in return, brings us more orders and benefits. If you are interested in any of our merchandise, make sure you feel free to contact us. Inquiry or visit to our company are warmly welcome. We sincerely hope to start a win-win and friendly partnership with you. You can see more details in our website.
  • Wide range, good quality, reasonable prices and good service, advanced equipment, excellent talents and continuously strengthened technology forces,a nice business partner.
    5 Stars By Joa from Italy - 2017.04.28 15:45
    Cooperate with you every time is very successful, very happy. Hope that we can have more cooperation!
    5 Stars By Sahid Ruvalcaba from California - 2018.05.22 12:13
    Write your message here and send it to us